Details of the Drug

General Information of Drug (ID: DMJWVCU)

• Drug Name: ZYC101a

Indication

Disease Entry	ICD 11	Status	REF
Cervical cancer	2C77.0	Phase 2/3	[1]

• Cross-matching ID: TTD ID: D07FGA

References

• [1] ClinicalTrials.gov (NCT00264732) A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix. U.S. National Institutes of Health.